Harnessing Health IT to Promote Equitable Care for Patients with Limited English Proficiency and Complex Care Needs

Not Applicable

Completed

• Conditions: Artificial Intelligence
• Interventions: Other: Complexity score and implementation

• Registration Number: NCT05860777
• Lead Sponsor: Mayo Clinic

Brief Summary

This is a pragmatic trial that will measure if the use of AI to identify patients with complex care needs and language barriers, as well as active reaching out to clinicians to offer the use of interpreter services will improve the frequency of interpreter use and reduce the time to first interpreter use

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2023-05-01
• Study First Submitted: 2023-05-08
• Study First Submitted QC: 2023-05-08
• Study First Posted: 2023-05-16
• Primary Completion: 2024-06-21
• Study Completion: 2024-09-30
• Status Verified: 2024-10
• Last Update Submitted: 2024-10-01
• Last Update Posted: 2024-10-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1923

Inclusion Criteria

• Adults with limited English proficiency and requiring an interpreter and having complex medical care needs (includes admitted to the ICU, prolonged hospital stay, requiring palliative care)
• Have research authorization

Read More

Exclusion Criteria

• Do not require an interpreter

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
Intervention	Complexity score and implementation	This is the group in units who are identified via AI model and in which interpreter services are actively reaching out to clinicians

Primary Outcome Measures

Name	Time	Method
Number of interpreters	12 months	the number of interpreters used among patients with LEP and complex care needs

Secondary Outcome Measures

Name	Time	Method
Change in time to interpreter use	12 months	The time measured in hours and minutes for an interpreter to be used for patients with LEP

Trial Locations

Locations (1)

Mayo Clinic Minnesota; 🇺🇸 Rochester, Minnesota, United States